Atlas Trials

A Study to Evaluate the Effects of ABX-1431 on Patients With Functional Dyspepsia

Clinical trial NCT02875678 · TERMINATED

Trial details

NCT number
NCT02875678
Sponsor
Abide Therapeutics
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Dyspepsia
Start date
2016-11-22
Primary completion
2017-08-07
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.